Hospitalisations with infections related to antimicrobial-resistant bacteria from the French nationwide hospital
M Opatowski1, P Tuppin2, K Cosker3
1Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Inserm, UVSQ, Institut Pasteur, Université Paris-Saclay,Paris,France.
Abstract:
Massive use of antibiotics has led to increased bacterial resistance to these drugs, making infections more difficult to treat. Few studies have assessed the overall antimicrobial resistance (AMR) burden, and there is a paucity of comprehensive data to inform health policies. This study aims to assess the overall annual incident number of hospitalised patients with AMR infection in France, using the National Hospital Discharge database. All incident hospitalisations with acute infections in 2016 were extracted. Infections which could be linked with an infecting microorganism were first analysed. Then, an extrapolation of bacterial species and resistance status was performed, according to age class, gender and infection site to estimate the total number of AMR cases. Resistant bacteria caused 139 105 (95% CI 127 920-150 289) infections, resulting in a 12.3% (95% CI 11.3-13.2) resistance rate. ESBL-producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus were the most common resistant bacteria (>50%), causing respectively 49 692 (95% CI 47 223-52 142) and 19 493 (95% CI 15 237-23 747) infections. Although assumptions are needed to provide national estimates, information from PMSI is comprehensive, covering all acute bacterial infections and a wide variety of microorganisms.
Insights
Antimicrobial resistance (AMR) infections in France caused over 139,000 hospitalizations in 2016. This highlights the significant burden of drug-resistant bacteria and the need for better public health strategies.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health Policy
Background:
- The widespread use of antibiotics has accelerated the rise of antimicrobial resistance (AMR), complicating infection treatment.
- Comprehensive data on the overall AMR burden is scarce, hindering effective health policy development.
- Estimating the national impact of AMR is crucial for public health planning.
Purpose of the Study:
- To quantify the annual incidence of hospitalised patients with AMR infections in France.
- To provide data-driven insights for informing national health policies on AMR.
- To assess the prevalence of specific resistant bacterial strains.
Main Methods:
- Utilized the National Hospital Discharge database (PMSI) for incident hospitalisations in 2016.
- Analyzed acute infections linked to specific microorganisms.
- Extrapolated bacterial species and resistance data by age, gender, and infection site for national estimates.
Main Results:
- Resistant bacteria caused an estimated 139,105 infections, with a 12.3% overall resistance rate.
- Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) were the most prevalent resistant bacteria.
- ESBL-producing Enterobacteriaceae accounted for 49,692 infections, and MRSA for 19,493 infections.
Conclusions:
- AMR infections represent a substantial public health challenge in France, necessitating targeted interventions.
- The study provides comprehensive national estimates despite inherent assumptions, underscoring the value of PMSI data.
- Further research and policy development are needed to combat the growing threat of antimicrobial resistance.
More Related Videos
06:36PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
Published on: April 9, 2013
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Hospitals-II
Nurses that work in...
Hospitals-I
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
RC Circuits: Discharging A Capacitor
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
